Journal of Hong Kong College of Radiologists

Volume 4 Number 1, 2001
Abstract

High Dose Chemotherapy for High Risk Primary Breast Cancer

WH Kwan
Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong

The potential role of high-dose chemotherapy in treating breast cancer patients with high risk of distant failure has been discussed. The weight of the present evidence is against the routine use of high-dose chemotherapy in the primary treatment for breast cancer. However, we still have to wait for the mature data form two large randomised trails (CALGB trial and Scandinavian trial) to be certain of the lack of survival benefit of this innovative approach. (J HK Coll Radiol 2001;1:18-20)

Key words : High-dose chemotherapy, Breast cancer, Primary treatment


Back to Previous Page